CN114213439A - Heterocyclic compound and organic electroluminescent device thereof - Google Patents

Heterocyclic compound and organic electroluminescent device thereof Download PDF

Info

Publication number
CN114213439A
CN114213439A CN202111551673.2A CN202111551673A CN114213439A CN 114213439 A CN114213439 A CN 114213439A CN 202111551673 A CN202111551673 A CN 202111551673A CN 114213439 A CN114213439 A CN 114213439A
Authority
CN
China
Prior art keywords
substituted
fluoro
cyano
nitro
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111551673.2A
Other languages
Chinese (zh)
Inventor
穆广园
庄少卿
董天天
张诒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei Sunshine Optoelectronics Material Co ltd
Original Assignee
Hubei Sunshine Optoelectronics Material Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei Sunshine Optoelectronics Material Co ltd filed Critical Hubei Sunshine Optoelectronics Material Co ltd
Priority to CN202111551673.2A priority Critical patent/CN114213439A/en
Publication of CN114213439A publication Critical patent/CN114213439A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1037Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/104Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with other heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The invention relates to a heterocyclic compound and an organic electroluminescent device thereof, wherein the compound is formed by bonding boron with a dibenzo-hexatomic heterocycle as a core and bonding with group nitrogen such as arylamine, carbazole and the like, and has both electricity supply and electricity receiving properties.

Description

Heterocyclic compound and organic electroluminescent device thereof
Technical Field
The invention relates to the field of photoelectric materials, in particular to a heterocyclic compound and an organic electroluminescent device thereof.
Background
Organic Light Emitting Diodes (OLEDs) have the advantages of high brightness, fast response, wide viewing angle, flexibility and the like, are widely applied to the field of display panels of products such as novel lighting lamps, smart phones and tablet computers, and as the applications of OLEDs are continuously promoted, people pay more attention to the research on core luminescent materials.
OLED light-emitting materials can be largely classified into three types according to the light-emitting mechanism. The first is a pure fluorescent material, capable of handling only 25% of singlet excitons. The second class is heavy metal phosphorescent materials, and due to the strong spin coupling effect of heavy metals, singlet excitons can be converted to triplet excitons through intersystem crossing (ISC), thereby achieving 100% internal quantum efficiency. However, heavy metal phosphorescent materials are expensive, toxic, and less stable, and the third is Thermally Activated Delayed Fluorescence (TADF), when the difference between the single and triple exciton energy levels of the molecule is Δ ESTSmaller, molecules can achieve a triplet to singlet state (T) upon excitation by thermal energy1-S1) The reverse intersystem transition (RISC) of the TADF structure forms singlet exciton radiation luminescence, thereby realizing 100 percent of internal quantum efficiency, and the TADF material has low cost and high efficiency and plays an important role in the industry.
Since boron atoms have an empty p-orbit and thus have electron-deficient properties, a series of TADF materials with improved properties can be obtained by utilizing the pz orbit of electron-deficient boron to conjugate with the pi-orbit of an organic conjugated system, which is a design hotspot of the current TADF new material system, however, no organic boron semiconductor luminescent material has the properties capable of meeting the industrial requirements so far, and therefore, in order to meet the increasing vigorous demands of industrial production, the research and development of boron-based materials with better comprehensive properties is urgently needed.
Disclosure of Invention
Aiming at the development trend of industrial technology and aiming at industrialization on the basis of the prior art, the invention aims to develop a novel heterocyclic compound containing boron atoms and nitrogen atoms, and the novel heterocyclic compound is applied to an organic electroluminescent device so as to reduce the driving voltage of the device, improve the luminous performance of the device and prolong the service life of the device.
The invention provides a heterocyclic compound, which has a structural general formula shown in formula 1:
Figure BDA0003417851460000011
wherein,
Figure BDA0003417851460000012
is represented by empty or a single bond or-X0-,X0Selected from O, S, N (R)4)、C(R5)(R6),
Q1 is a group represented by the following formula 2:
Figure BDA0003417851460000021
R7and R8Or R8And R9Is a group bonded to the above formula 1, R7-R9Wherein the group not bound to formula 1 is hydrogen;
X1、X2each independently selected from O, S, N (R)10)、C(R11)(R12),X1、X2Are the same or different from each other;
q2 is C6-30A carbocyclic group of2-30A heterocyclic group of (a);
R1-R3are the same or different from each other and are each independently selected from hydrogen, fluoro, nitro, cyano, C1-20Alkyl of (C)1-20Alkoxy group of (C)3-20Cycloalkyl of, C2-20Heterocycloalkyl of (A), C6-30Aryl of (C)3-30Heteroaryl of (A), C6-30Aryloxy group of (A), C6-30Arylthio of, R1Is singly bound to formula 1, R2And R3Respectively connected with single bonds of formula 1 or combined into rings;
R4-R6、R10-R12are the same or different from each other and are each independently selected from C1-20Alkyl of (C)6-30Aryl group of (1).
Further, R4-R6Each independently selected from methyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl.
Further, R10-R12Each independently selected from methyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl.
Further, Q2 is represented by one of formulas A1-A4:
Figure BDA0003417851460000022
wherein, X3、X4、X5Each independently selected from O, S, N (R)19)、C(R20)(R21),X3、X4、X5Are the same or different from each other;
R13-R18each independently selected from hydrogen, fluoro, nitro, cyano, C1-6Unsubstituted or substituted by fluoro, nitro, cyano, C1-6Phenyl substituted by alkyl, unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl-substituted biphenylyl unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl, phenyl-substituted naphthyl, unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl, phenyl-substituted dibenzofuranyl, unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl, phenyl-substituted dibenzothienyl, unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl, phenyl-substituted fluorenyl, unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl, phenyl-substituted carbazolyl, R13-R18Are the same or different from each other;
R19-R21identical or different from each other, each independently selected from methyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl.
Further, a1 is further expressed as:
Figure BDA0003417851460000023
Figure BDA0003417851460000031
a2 is further expressed as:
Figure BDA0003417851460000032
a3 is further expressed as:
Figure BDA0003417851460000033
Figure BDA0003417851460000034
a4 is further expressed as:
Figure BDA0003417851460000035
further, R1Independently hydrogen, or a group represented by B1-B3:
Figure BDA0003417851460000036
wherein, X6Selected from O, S, N (R)22)、C(R23)(R24),R22-R24Identical or different from each other, each independently selected from methyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl.
Further, R2And R3Each independently of the others is hydrogen, fluoro, nitro, cyano, methyl, tert-butyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl, or a group represented by C1,
Figure BDA0003417851460000037
wherein, X7Selected from O, S, N (R)25)、C(R26)(R27),R25-R27Each independently selected from methyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl.
Further, the heterocyclic compound represented by the formula (1) is selected from the following structural formulas:
Figure BDA0003417851460000041
Figure BDA0003417851460000051
Figure BDA0003417851460000061
Figure BDA0003417851460000071
Figure BDA0003417851460000081
Figure BDA0003417851460000091
Figure BDA0003417851460000101
the heterocyclic compound provided by the invention contains a dibenzohexatomic heterocycle with an electron-deficient boron bonded bond, is bonded with group ring nitrogen such as arylamine and carbazole which supply electrons, has bipolar characteristics of both electric property and power supply property, and can form a stable luminescent material by adjusting the electric property of the compound supplied/received by the dibenzohexatomic heterocycle; multiple resonance can be generated between N atoms and B atoms in the compound, so that the highest occupied molecular orbital HOMO and the lowest unoccupied molecular orbital LOMO in a molecule are separated, and the compound shows TADF (TADF) characteristics; the compound takes a multi-element condensed structure formed by bonding boron with a dibenzo-hexatomic heterocycle as a main body, has stronger rigidity, and can effectively reduce the loss of non-radiative transition of excited molecules caused by vibration relaxation, thereby obtaining higher luminous efficacy.
Detailed Description
It should be understood that the detailed description and specific examples, while indicating the present invention, are given by way of illustration and explanation only, not limitation.
Synthesis example 1: synthesis of Compound (12)
After adding 35mmol,9.90g of m-bromoiodobenzene, 30mmol,5.08g of diphenylamine, 60mmol,5.76g of sodium tert-butoxide, 0.15mmol,0.14g of dipalladium tris-benzylidene acetone, 0.15mmol,0.04g of tri-tert-butylphosphine tetrafluoroborate and 100mL of toluene into a reactor, stirring and mixing the mixture thoroughly, heating and refluxing the mixture under the protection of nitrogen, monitoring the completion of the reaction in the liquid phase, cooling the mixture to room temperature, adding 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine (30mmol,12.47g) into the reactor, stirring and mixing the mixture thoroughly, continuing heating and refluxing the reaction under the protection of nitrogen, monitoring the completion of the reaction in the liquid phase, cooling the mixture to room temperature, extracting the reaction solution with a mixture of water and dichloromethane, drying the organic phase magnesium sulfate, concentrating the dried mixture, purifying and separating the mixture in a silica gel column with a mixed solvent of 1:10 dichloromethane and petroleum ether, thus, 12.06g of the compound represented by the following chemical formula (12a) was obtained in a yield of 61%;
Figure BDA0003417851460000111
dissolving the compound (10mmol,6.59g) represented by the formula (12a) in 50mL of tert-butyl benzene solution in a reactor, cooling the reaction solution to-40 ℃, slowly adding 32.5mL of 2.5M N-hexane tert-butyl lithium solution dropwise under the protection of nitrogen, stirring for 0.5-2h while maintaining the temperature, adding boron tribromide (15mmol,3.76g), heating the reaction solution to room temperature, stirring for 0.5-2h, cooling the reaction solution to 0 ℃, adding N, N-diisopropylethylamine (10mmol,1.29g), heating to 120 ℃ for reflux reaction, monitoring the completion of the reaction in a liquid phase, cooling to room temperature, quenching the reaction solution with acetic acid, extracting the reaction solution with a mixture of water and dichloromethane, drying an organic phase magnesium sulfate, concentrating, purifying and separating in a silica gel column with a mixed solvent of 1:10 dichloromethane and petroleum ether, thereby obtaining 2.09g of the compound represented by the following formula (12), the yield is 33%;
Figure BDA0003417851460000112
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 632.4762; nuclear magnetism δ (ppm) is 8.82(1H), 8.19(1H), 7.78(2H), 7.69(1H), 7.47(1H), 7.35(2H), 7.29(1H), 7.21(1H), 7.11(6H), 6.98-7.04(5H), 6.87(1H), 6.72(1H), 6.45(1H), 6.24 (1H).
Synthesis example 2: synthesis of Compound (15)
The procedure of example 1 was repeated except for substituting m-bromoiodobenzene with 10- (3-bromo-5-iodobenzene) -10 h-phenoxazine (35mmol,16.24g), diphenylamine with 4,4' -dicyanodianiline (30mmol,6.58g) and 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine with 2-chloro-N-phenylphenoxathiin-3-amine (30mmol,9.77g), to give 13.45g of the compound represented by the following formula (15a) in 56% yield;
Figure BDA0003417851460000121
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 8.00g of the compound represented by (15a) described in example 1 to give 2.32g of the compound represented by the following formula (14) in a yield of 30%;
Figure BDA0003417851460000122
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 773.6815; nuclear magnetism δ (ppm) is 8.52(1H), 8.33(1H), 7.82(2H), 7.57(1H), 7.48(3H), 7.39(1H), 7.28(3H), 7.19(3H), 7.05(1H), 6.96(2H), 6.89(2H), 6.83(1H), 6.77(2H), 6.70(1H), 6.58(2H), 5.58(1H), 5.51 (1H).
Synthetic example 3: synthesis of Compound (20)
The procedure of example 1 was repeated except for replacing the diphenylamine in example 1 with dimethyldiphenylamine (30mmol,5.92g) and replacing the 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine with 3-chloro-N-mesitylene-9, 9,10, 10-tetramethyl-9, 10-dihydroheteroanthracen-2-amine (30mmol,12.12g), to give 13.57g of the compound represented by the following formula (20a) in a yield of 67%;
Figure BDA0003417851460000123
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 6.75g of the compound represented by (20a) above to give 2.34g of the compound represented by the following formula (20) in a yield of 36%;
Figure BDA0003417851460000131
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 648.7067; nuclear magnetism δ (ppm) is 8.37(1H), 8.25(1H), 8.11(1H), 7.67(2H), 7.54(1H), 7.42(2H), 7.31(1H), 7.23(3H), 7.04(2H), 6.83(2H), 6.24(1H), 6.15(1H), 2.26(3H), 2.31(3H), 2.19(9H), 1.78 (12H).
Synthetic example 4: synthesis of Compound (28)
The procedure of example 1 was repeated except for replacing diphenylamine with 9-hydrogen-carbazole (30mmol,5.02g) and replacing 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine with N- ([1,1' -biphenyl ] -4-yl) -2-chloro-9, 9-dimethyl-9-hydro-xanthen-3-amine (30mmol,12.36g), thereby obtaining 12.35g of a compound represented by the following chemical formula (28a) in a yield of 63%;
Figure BDA0003417851460000132
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 6.53g of the compound represented by (28a) described in example 1 to give 2.13g of the compound represented by the following formula (28) in a yield of 34%;
Figure BDA0003417851460000133
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 626.5608; nuclear magnetism δ (ppm) is 8.65(1H), 8.37(1H), 8.18(1H), 8.02(1H), 7.93(1H), 7.75(2H), 7.64(1H), 7.56(3H), 7.38-7.47(6H), 7.31(3H), 7.22(1H), 7.10(1H), 7.01(1H), 6.82(1H), 6.63(1H), 1.79 (6H).
Synthesis example 5: synthesis of Compound (37)
The procedure of example 1 was repeated except for replacing m-bromoiodobenzene with 3-bromo-5-iodo-N, N-diphenylaniline (35mmol,15.75g), diphenylamine with 3, 6-dimethyl-9-hydro-carbazole (30mmol,5.86g) and 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine with 3-chloro-N-phenylthianthrene-2-amine (30mmol,10.26g) in example 1 to give 14.01g of the compound represented by the following formula (37a) in a yield of 60%;
Figure BDA0003417851460000141
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 7.78g of the compound represented by (37a) described in example 1 to give 2.41g of the compound represented by the following formula (37) in a yield of 32%;
Figure BDA0003417851460000142
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 751.7762; nuclear magnetic δ (ppm) is 9.07(1H), 8.68(1H), 8.53(1H), 8.19(1H), 7.92(1H), 7.74(2H), 7.63(1H), 7.47(4H), 7.35(2H), 7.22(2H), 7.14(3H), 7.05(4H), 6.94(2H), 6.72(1H), 5.26(1H), 5.14(1H), 2.38(3H), 2.29 (3H).
Synthetic example 6: synthesis of Compound (43)
The diphenylamine in example 1 was replaced with 12-hydro-benzo [4,5] thieno [2,3-a ] carbazole (30mmol,8.20g) and 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine was replaced with 3-chloro-9, 9-dimethyl-N- (4-nitrophenyl) -9-hydro-thiaanthracen-2-amine (30mmol,11.91g), and the other synthetic procedures were the same as in example 1, whereby 11.16g of the compound represented by the following chemical formula (43a) was obtained in a yield of 50%;
Figure BDA0003417851460000143
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 7.44g of the compound represented by (43a) above, thereby obtaining 2.66g of a compound represented by the following formula (43) in a yield of 37%;
Figure BDA0003417851460000151
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 717.6625; nuclear magnetism δ (ppm) is 9.12(1H), 8.89(1H), 8.62(1H), 8.53(1H), 8.47(1H), 8.25(2H), 8.17(1H), 8.11(1H), 8.02(1H), 7.86(1H), 7.75(1H), 7.63(1H), 7.48(3H), 7.39(1H), 7.26(1H), 7.11(1H), 6.90(1H), 6.82(1H), 6.76(1H), 1.79 (6H).
Synthetic example 7: synthesis of Compound (54)
The procedure of example 1 was repeated except for substituting m-bromoiodobenzene with 9- (3-bromo-5-iodophenyl) -hydrogen-carbazole (35mmol,15.68g), substituting diphenylamine with 10-hydro-phenothiazine (30mmol,5.98g), and substituting 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine with 3-chloro-9, 9,10, 10-tetramethyl-N- (p-tolyl) -9, 10-dihydroanthracene-2-amine (30mmol,11.27g), and obtaining 14.42g of the compound represented by the following formula (54a) in a yield of 59%;
Figure BDA0003417851460000152
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 8.14g of the compound represented by (54a) above to give 2.60g of the compound represented by the following formula (54) in a yield of 33%;
Figure BDA0003417851460000153
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 787.8354; nuclear magnetism δ (ppm) is 8.37(1H), 8.22(2H), 8.10(1H), 7.95(1H), 7.82(1H), 7.75(2H), 7.62(2H), 7.50(2H), 7.37(2H), 7.24(2H), 7.16(3H), 7.10(1H), 6.98(3H), 6.74(1H), 6.67(1H), 6.54(1H), 6.45(1H), 2.26(3H), 1.79 (12H).
Synthesis example 8: synthesis of Compound (57)
The diphenylamine in example 1 was replaced with 3, 7-diphenyl-10 h-phenoxazine (30mmol,10.06g), 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine was replaced with 3-chloro-N-phenyldibenzo [ b, e ] [1,4] dioxin-2-amine (30mmol,9.29g), and the other synthetic procedures were the same as in example 1, whereby 13.59g of the compound represented by the following formula (57a) was obtained in a yield of 63%;
Figure BDA0003417851460000161
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 7.19g of the compound represented by (57a) described in this example to give 2.15g of the compound represented by the following formula (57) in a yield of 31%;
Figure BDA0003417851460000162
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 692.5783; nuclear magnetism δ (ppm) is 8.28(1H), 8.11(1H), 7.92(4H), 7.75(2H), 7.63(1H), 7.52(5H), 7.41(1H), 7.34(1H), 7.29(3H), 7.20(2H), 7.11(2H), 7.02(2H), 6.88(1H), 6.72(1H), 6.21(1H), 6.14 (1H).
Synthetic example 9: synthesis of Compound (62)
The diphenylamine in example 1 was replaced with 3, 7-difluoro-10-hydro-phenothiazine (30mmol,2.35g) and 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine was replaced with N- ([1,1' -biphenyl ] -4-yl) -3-chlorophenoxazin-2-amine (30mmol,12.05g), and the other synthesis procedures were the same as in example 1, whereby 13.87g of the compound represented by the following formula (62a) was obtained in 65% yield;
Figure BDA0003417851460000163
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 7.11g of the compound represented by (62a) above to give 2.40g of the compound represented by the following formula (62) in a yield of 35%;
Figure BDA0003417851460000171
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 684.5895; nuclear magnetism δ (ppm) is 8.34(1H), 8.18(1H), 8.05(1H), 7.72(3H), 7.56(2H), 7.47(2H), 7.39(1H), 7.31(3H), 7.23(1H), 7.16(1H), 7.04(1H), 6.93(1H), 6.85(2H), 6.69(1H), 6.42(1H), 6.34 (1H).
Synthetic example 10: synthesis Compound (67)
The procedure of example 1 was otherwise the same except for replacing 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine in example 1 with 2-chloro-N-phenylthianthren-1-amine (30mmol,10.26g), whereby 10.53g of a compound represented by the following formula (67a) was obtained in a yield of 60%;
Figure BDA0003417851460000172
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 5.85g of the compound represented by (67a) above, thereby obtaining 2.12g of the compound represented by the following formula (67) in a yield of 38%;
Figure BDA0003417851460000173
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 558.5189; nuclear magnetism δ (ppm) is 8.75(1H), 8.42(1H), 7.78(4H), 7.69(1H), 7.44(1H), 7.38(2H), 7.29(5H), 7.17(2H), 7.06(1H), 6.87(1H), 7.70(2H), 6.16 (2H).
Synthetic example 11: synthesis of Compound (77)
The diphenylamine in example 1 was replaced with N- (4- (tert-butyl) phenyl) dibenzofuran-3-amine (30mmol,9.46g) and 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine was replaced with 3-chloro-N, 10-diphenyl-10 h-thiophenazine-4-amine (30mmol,12.03g), and the other synthesis procedures were the same as in example 1, whereby 13.04g of the compound represented by the following formula (77a) was obtained in 55% yield;
Figure BDA0003417851460000181
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 7.90g of the compound represented by (77a) above to give 2.52g of the compound represented by the following formula (77) in a yield of 33%;
Figure BDA0003417851460000182
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 763.7703; nuclear magnetism δ (ppm) is 8.52(1H), 8.21(1H), 8.05(1H), 7.81(4H), 7.72(1H), 7.57(1H), 7.46(1H), 7.38(3H), 7.22-7..31(5H), 7.16(1H), 7.09(2H), 6.98(3H), 6.89(1H), 6.70(2H), 6.21(2H), 1.35 (9H).
Synthetic example 12: synthesis of Compound (82)
The procedure of example 1 was repeated except for substituting diphenylamine in example 1 with bis ([1,1' -biphenyl ] -4-yl) amine (30mmol,9.64g) and substituting 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine with 3-chloro-N- (4-fluorophenyl) phenoxathiin-4-amine (30mmol,10.31g), thereby obtaining 12.64g of a compound represented by the following formula (82a) in a yield of 57%;
Figure BDA0003417851460000183
the same procedure as in example 1 was repeated except for replacing the compound represented by (12a) in example 1 with 2.57g of the compound represented by (82a) in the present example to obtain g of a compound represented by the following formula (82) in a yield of 36%;
Figure BDA0003417851460000184
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 712.6526; nuclear magnetism δ (ppm) is 8.92(1H), 8.76(1H), 8.15(1H), 7.94(1H), 7.76(4H), 7.65(1H), 7.56(2H), 7.45(4H), 7.39(1H), 7.31(3H), 7.26(1H), 7.19(3H), 7.11(1H), 7.04(2H), 6.95(1H), 6.82(1H), 6.22(1H), 6.17 (1H).
Synthetic example 13: synthesis of Compound (87)
The diphenylamine in example 1 was replaced with 9-hydro-carbazole (30mmol,5.02g), 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine was replaced with 2-chloro-N- (naphthalen-2-yl) dibenzo [ b, e ] [1,4] dioxin-1-amine (30mmol,10.79g), and the other synthesis procedures were the same as in example 1, whereby 10.64g of the compound represented by the following formula (87a) was obtained in a yield of 59%;
Figure BDA0003417851460000191
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 6.01g of the compound represented by (87a) described in this example to give 2.18g of the compound represented by the following formula (87) in a yield of 38%;
Figure BDA0003417851460000192
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 574.4408; nuclear magnetism δ (ppm) is 8.67(1H), 8.32(1H), 8.18(1H), 8.06(1H), 7.98(1H), 7.87(1H), 7.70(1H), 7.44-7.54(4H), 7.38(2H), 7.31(1H), 7.20(1H), 7.11(3H), 7.04(2H), 6.77(1H), 6.69(1H), 6.54 (1H).
Synthesis example 14: synthesis of Compound (104)
The diphenylamine in example 1 was replaced with 3, 6-di-tert-butyl-9 h-carbazole (30mmol,8.38g), 3-chloro-di (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine was replaced with 4- ((2-chlorophenoxain-1-yl) amino) cyanobenzene (30mmol,10.52g), and the other synthetic procedures were the same as in example 1, whereby 11.62g of the compound represented by the following chemical formula (104a) was obtained with a yield of 55%;
Figure BDA0003417851460000193
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 7.04g of the compound represented by (104a) described in this example, whereby 2.30g of the compound represented by the following formula (104) was obtained in a yield of 34%;
Figure BDA0003417851460000201
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 677.6768; nuclear magnetism δ (ppm) is 9.12(1H), 8.79(1H), 8.22(1H), 8.13(1H), 7.87(1H), 7.76(1H), 7.69(2H), 7.61(2H), 7.54(1H), 7.47(1H), 7.42(1H), 7.29(1H), 7.22(1H), 7.13(1H), 7.02(1H), 6.69(1H), 1.47(9H), 1.44 (9H).
Synthetic example 15: synthesis of Compound (112)
The procedure of example 1 was repeated except for substituting diphenylamine in example 1 with 5-phenyl-5, 10-dihydrophenazine (30mmol,7.75g), and 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine with 3-chloro-N- (4-fluorophenyl) phenoxathiin-4-amine (30mmol,10.31g), to give 11.77g of a compound represented by the following formula (112a) in a yield of 58%;
Figure BDA0003417851460000202
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 6.76g of the compound represented by (112a) in this example to give 1.95g of the compound represented by the following formula (112) in a yield of 30%;
Figure BDA0003417851460000203
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 649.5479; nuclear magnetism δ (ppm) is 8.92(1H), 8.11(1H), 7.78(2H), 7.71(1H), 7.47(1H), 7.35(2H), 7.21-7.28(5H), 7.16(1H), 7.11(2H), 7.03(1H), 6.97(2H), 6.89(1H), 6.81(1H), 6.76(1H), 6.68(1H), 6.21(1H), 6.14 (1H).
Synthetic example 16: synthesis of Compound (125)
The diphenylamine in example 1 was replaced with 10-hydro-phenoxazine-3, 7-dicyanobenzene (30mmol,7.00g), and 3-chloro-bis (dibenzo [ b, e ] [1,4] dioxin-2-yl) amine was replaced with 2-chloro-N- (naphthalen-2-yl) thianthren-1-amine (30mmol,11.76g), and the other synthesis procedures were the same as in example 1, whereby 10.70g of the compound represented by the following formula (125a) was obtained in 51% yield;
Figure BDA0003417851460000204
the same procedures used in example 1 were repeated except for replacing the compound represented by (12a) in example 1 with 7.00g of the compound represented by (125a) described in this example to give 2.35g of the compound represented by the following formula (125) in a yield of 35%;
Figure BDA0003417851460000211
the compound obtained was analyzed and found to have the following results: mass spectrometer MALDI-TOF-MS (m/z) 672.5913; nuclear magnetism δ (ppm) is 8.51(1H), 8.42(1H), 8.04(1H), 7.96(1H), 7.85(1H), 7.71(1H), 7.54(1H), 7.49(1H), 7.42(1H), 7.33-7.38(4H), 7.28(1H), 7.17(2H), 7.11(1H), 7.02(1H), 6.77(1H), 6.25(1H), 6.17 (1H).
Device example 1
And (3) sequentially ultrasonically cleaning the glass substrate with the 50nm ITO transparent film for 10min by using acetone, isopropanol and deionized water, drying for 2h in vacuum at 105 ℃, then washing for 15min by using UV ozone, and conveying the ITO glass substrate to a vacuum evaporation machine.
Vacuum evaporating 4,4' -tris [ 2-naphthyl (phenyl) amino ] triphenylamine (2T-NATA) on the surface of the side on which the ITO film is formed to form a 10nm thick hole injection layer;
next, on the above hole injection layer, N '-diphenyl-N, N' - (1-naphthyl) -1,1 '-biphenyl-4, 4' -diamine (NPB) was vacuum-evaporated to form a 60nm thick hole transport layer;
next, on the above hole transport layer, 9, 10-bis (2-naphthyl) Anthracene (ADN) (95 wt% as a light emitting host material) and the compound 12 prepared in the above synthesis example 1(5 wt% as a light emitting guest material) were co-vacuum evaporated to form a light emitting layer with a thickness of 20 nm;
next, 3'- [5' - [3- (3-pyridyl) phenyl ] [1,1':3',1 '-terphenyl ] -3, 3' -diyl ] bipyridine (TmPyPB) was vacuum-evaporated on the above light-emitting layer to form an electron transporting layer having a thickness of 15 nm;
next, on the above electron transport layer, lithium fluoride (LiF) was vacuum-evaporated to form an electron injection layer having a thickness of 1nm
Finally, magnesium aluminum alloy (Mg/Al) is vacuum evaporated on the electron injection layer to form a cathode with a diameter of 100 nm.
Device example 2 to device example 16
An organic electroluminescent device was prepared in the same manner as in device example 1, except that compound 15, compound 20, compound 28, compound 37, compound 43, compound 54, compound 57, compound 62, compound 67, compound 77, compound 82, compound 87, compound 104, compound 112, compound 125 were used instead of compound 12 prepared in synthesis example 1 described above, respectively.
Comparative device example 17 and comparative device example 18
An organic electroluminescent device was produced in the same manner as in device example 1, except that 4,4 '-bis (9-ethyl-3-carbazolevinyl) -1,1' -biphenyl (BCzVBi) and the following compound a-1 were used instead of compound 12 produced in synthesis example 1, respectively;
Figure BDA0003417851460000212
the organic electroluminescent devices prepared in the above device examples were subjected to performance tests, and the results are shown in table 1:
TABLE 1
Figure BDA0003417851460000221
As can be seen from the data in table 1 above, the compound provided by the present invention, which is formed by bonding boron-bonded dibenzo-six-membered heterocycle as a core and is bonded with group ring nitrogen such as arylamine and carbazole, has a conjugated planar structure with stronger rigidity due to the adjustment of the electrical supply and the electrical receiving of the dibenzo-six-membered heterocycle on the compound, so that the compound material realizes highly efficient and stable TADF luminescence characteristics.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.

Claims (10)

1. A heterocyclic compound has a structural general formula shown in formula 1:
Figure FDA0003417851450000011
wherein,
Figure FDA0003417851450000012
is represented by empty or a single bond or-X0-, said X0Selected from O, S, N (R)4)、C(R5)(R6),
Q1 is a group represented by the following formula 2:
Figure FDA0003417851450000013
R7and R8Or R8And R9Is a group bonded to the above formula 1, R7-R9Wherein the group not bound to formula 1 is hydrogen;
X1、X2are respectively independentIs selected from O, S, N (R)10)、C(R11)(R12),X1、X2Are the same or different from each other;
q2 is C6-30A carbocyclic group of2-30A heterocyclic group of (a);
R1-R3are the same or different from each other and are each independently selected from hydrogen, fluoro, nitro, cyano, C1-20Alkyl of (C)1-20Alkoxy group of (C)3-20Cycloalkyl of, C2-20Heterocycloalkyl of (A), C6-30Aryl of (C)3-30Heteroaryl of (A), C6-30Aryloxy group of (A), C6-30Arylthio of, R1Is singly bound to formula 1, R2And R3Respectively connected with single bonds of formula 1 or combined into rings;
R4-R6、R10-R12are the same or different from each other and are each independently selected from C1-20Alkyl of (C)6-30Aryl group of (1).
2. The heterocyclic compound according to claim 1, wherein R is4-R6Each independently selected from methyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl.
3. The heterocyclic compound according to claim 1, wherein R is10-R12Each independently selected from methyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl.
4. The heterocyclic compound according to claim 1, wherein Q2 is represented by one of formulae a1-a 4:
Figure FDA0003417851450000014
wherein, X3、X4、X5Each independently selected from O, S, N (R)19)、C(R20)(R21),X3、X4、X5Are the same or different from each other;
R13-R18each independently selected from hydrogen, fluoro, nitro, cyano, C1-6Unsubstituted or substituted by fluoro, nitro, cyano, C1-6Phenyl substituted by alkyl, unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl-substituted biphenylyl unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl, phenyl-substituted naphthyl, unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl, phenyl-substituted dibenzofuranyl, unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl, phenyl-substituted dibenzothienyl, unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl, phenyl-substituted fluorenyl, unsubstituted or substituted by fluoro, nitro, cyano, C1-6Alkyl, phenyl-substituted carbazolyl, R13-R18Are the same or different from each other;
R19-R21identical or different from each other, each independently selected from methyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl.
5. A heterocyclic compound according to claim 4, characterized in that said A1 is further represented by:
Figure FDA0003417851450000021
the a2 is further expressed as:
Figure FDA0003417851450000022
the a3 is further expressed as:
Figure FDA0003417851450000023
Figure FDA0003417851450000024
the a4 is further expressed as:
Figure FDA0003417851450000025
6. the heterocyclic compound according to claim 1, wherein R is1Independently hydrogen, or a group represented by B1-B3:
Figure FDA0003417851450000026
wherein, X6Selected from O, S, N (R)22)、C(R23)(R24),R22-R24Identical or different from each other, each independently selected from methyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl.
7. The heterocyclic compound according to claim 1, wherein R is2And R3Each independently of the others is hydrogen, fluoro, nitro, cyano, methyl, tert-butyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl, or a group represented by C1,
Figure FDA0003417851450000031
wherein, X7Selected from O, S, N (R)25)、C(R26)(R27),R25-R27Each independently selected from methyl, phenyl unsubstituted or substituted by fluoro, nitro, cyano, methyl, tert-butyl.
8. A heterocyclic compound according to claim 1, characterized in that the heterocyclic compound is selected from the following structural formulae:
Figure FDA0003417851450000032
Figure FDA0003417851450000041
Figure FDA0003417851450000051
Figure FDA0003417851450000061
Figure FDA0003417851450000071
Figure FDA0003417851450000081
Figure FDA0003417851450000091
9. an organic electroluminescent device mainly comprises a cathode, an anode and an organic layer between the two electrodes, and is characterized in that: the organic layer between the two electrodes comprises a heterocyclic compound according to any of claims 1 to 8.
10. The organic electroluminescent device according to claim 9, wherein the organic layer between the two electrodes comprises a light-emitting layer composed of a light-emitting host and a light-emitting guest comprising the heterocyclic compound according to any one of claims 1 to 8.
CN202111551673.2A 2021-12-17 2021-12-17 Heterocyclic compound and organic electroluminescent device thereof Pending CN114213439A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111551673.2A CN114213439A (en) 2021-12-17 2021-12-17 Heterocyclic compound and organic electroluminescent device thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111551673.2A CN114213439A (en) 2021-12-17 2021-12-17 Heterocyclic compound and organic electroluminescent device thereof

Publications (1)

Publication Number Publication Date
CN114213439A true CN114213439A (en) 2022-03-22

Family

ID=80703577

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111551673.2A Pending CN114213439A (en) 2021-12-17 2021-12-17 Heterocyclic compound and organic electroluminescent device thereof

Country Status (1)

Country Link
CN (1) CN114213439A (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107417715A (en) * 2017-07-14 2017-12-01 瑞声科技(南京)有限公司 A kind of electroluminescent organic material and its luminescent device
KR20190037176A (en) * 2017-09-28 2019-04-05 주식회사 엘지화학 Compound and organic light emitting device comprising same
CN110943176A (en) * 2018-09-21 2020-03-31 三星显示有限公司 Organic light emitting device and apparatus including the same
WO2021086148A1 (en) * 2019-10-31 2021-05-06 에스에프씨 주식회사 Polycyclic compound and organoelectro luminescent device using same
WO2021107737A1 (en) * 2019-11-29 2021-06-03 주식회사 엘지화학 Organic light-emitting element
CN113727985A (en) * 2019-09-10 2021-11-30 株式会社Lg化学 Compound and organic light emitting device including the same
CN113924307A (en) * 2019-11-29 2022-01-11 株式会社Lg化学 Polycyclic compound and organic light-emitting element comprising same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107417715A (en) * 2017-07-14 2017-12-01 瑞声科技(南京)有限公司 A kind of electroluminescent organic material and its luminescent device
KR20190037176A (en) * 2017-09-28 2019-04-05 주식회사 엘지화학 Compound and organic light emitting device comprising same
CN110943176A (en) * 2018-09-21 2020-03-31 三星显示有限公司 Organic light emitting device and apparatus including the same
CN113727985A (en) * 2019-09-10 2021-11-30 株式会社Lg化学 Compound and organic light emitting device including the same
WO2021086148A1 (en) * 2019-10-31 2021-05-06 에스에프씨 주식회사 Polycyclic compound and organoelectro luminescent device using same
WO2021107737A1 (en) * 2019-11-29 2021-06-03 주식회사 엘지화학 Organic light-emitting element
CN113924307A (en) * 2019-11-29 2022-01-11 株式会社Lg化学 Polycyclic compound and organic light-emitting element comprising same

Similar Documents

Publication Publication Date Title
TWI306890B (en) Material for organic electroluminscence devices and organic electroluminescence device using the material
TWI544056B (en) Phosphorescent organic light emitting devices combined with hole transport material having high operating stability
JP4227628B2 (en) Compound and organic light emitting device
CN103992305B (en) 1,8-naphthalimide derivative compound organic electroluminescent main material and device
KR20110123701A (en) Anthracene-based compound and organic electroluminescent devices comprising the same
KR20160057018A (en) Amine compound and organic electroluminescent device using the same
JPWO2014097813A1 (en) Organic electroluminescence device
CN102775398A (en) Novel bipolar material and application thereof
JP6716145B1 (en) Boron-containing compound and organic EL device
Moorthy et al. Blue light-emitting and hole-transporting amorphous molecular materials based on diarylaminobiphenyl-functionalized bimesitylenes
JP2022545320A (en) Aromatic amine compound, capping layer material, and light-emitting device
TWI750355B (en) Organic electroluminescent device
JP2012116794A (en) QUINOLINO[3,2,1-kl]PHENOXAZINE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING THE SAME
KR20070079680A (en) High-efficient organic light emitting material and organic light emitting diode
KR20150066429A (en) Organic Compound and Organic Light Emitting Diode Devices using the same
KR20110106192A (en) Fused arylamine compound and organic electroluminescent devices comprising the same
KR20130051321A (en) Novel tetiary aryl amine and organic electroluminescent device using the same
Chen et al. Engineering the excited-state properties of purely organic intramolecular and intermolecular charge transfer emitters towards high-performance fluorescent OLEDs
KR101327301B1 (en) Amine derivative as hole transporting material and organic electroluminescent device using the same
KR101159729B1 (en) Organic Light Emitting Material and Organic Light Emitting Diode Having The Same
CN112125835A (en) Hole transport material and organic electroluminescent device using same
KR102533896B1 (en) Boron-based compound and organic light emitting device comprising the same
CN103420910A (en) Electron-transport blue luminescent material and use thereof
CN114213439A (en) Heterocyclic compound and organic electroluminescent device thereof
CN114133408A (en) Boron-based compound and application thereof in organic electroluminescent device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination